MCLEAN, Va., July 31, 2017 -- Gladstone Investment Corporation (NASDAQ:GAIN) announces the following event:
| What: | Gladstone Investment Corporation's First Quarter Ended June 30, 2017 Earnings Call & Webcast | |
| When: | Wednesday, August 2, 2017 @ 8:30 a.m. EDT | |
| Where: | http://edge.media-server.com/m/p/4apufr4f | |
| How: | By webcast -- Log on to the web at the address above | |
| By phone – please call (855) 376-7516 | ||
| Contact: | Gladstone Investment Corporation, +1-703-287-5893 |
A conference call replay will be available after the call and will be accessible through September 2, 2017. To hear the replay, please dial (855) 859-2056 and use playback conference number 54415702.
If you are unable to participate during the live webcast, the call will be archived on the website www.gladstoneinvestment.com. The event will be archived and available for replay on the Company’s website through October 2, 2017.
Gladstone Investment Corporation is a publicly traded business development company that seeks to make debt and equity investments in lower middle market businesses in the United States in connection with acquisitions, changes in control and recapitalizations.
For further information: Gladstone Investment Corporation, +1-703-287-5893


Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Italy Fines Apple €98.6 Million Over App Store Dominance
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



